News
NAII
2.390
-1.24%
-0.030
Weekly Report: what happened at NAII last week (0615-0619)?
Weekly Report · 6d ago
Weekly Report: what happened at NAII last week (0608-0612)?
Weekly Report · 06/15 10:07
Weekly Report: what happened at NAII last week (0601-0605)?
Weekly Report · 06/08 10:04
Weekly Report: what happened at NAII last week (0525-0529)?
Weekly Report · 06/01 10:07
Weekly Report: what happened at NAII last week (0518-0522)?
Weekly Report · 05/25 10:10
Natural Alternatives reports Q3 results
Seeking Alpha · 05/19 19:52
Earnings Scheduled For May 19, 2026
Benzinga · 05/19 11:11
Natural Alternatives Q3 net loss widens on factory underutilization
Reuters · 05/19 10:23
Natural Alternatives Intl Q3 EPS $(0.72) Down From $(0.37) YoY, Sales $35.482M Up From $28.766M YoY
Benzinga · 05/19 10:19
NATURAL ALTERNATIVES INTERNATIONAL, INC. ANNOUNCES 2026 Q3 AND YTD RESULTS
Reuters · 05/19 10:15
*Natural Alternatives 3Q Sales $35.5M >NAII
Dow Jones · 05/19 10:15
Press Release: Natural Alternatives -2-
Dow Jones · 05/19 10:15
*Natural Alternatives 3Q Loss $4.31M >NAII
Dow Jones · 05/19 10:15
Press Release: Natural Alternatives International, Inc. Announces 2026 Q3 and YTD Results
Dow Jones · 05/19 10:15
*Natural Alternatives 3Q Loss/Shr 72c >NAII
Dow Jones · 05/19 10:15
Natural Alternatives’ Q3 FY26 net loss widens 97% to $4.31 million
PUBT · 05/19 10:06
Natural Alternatives: Fiscal Q3 Earnings Snapshot
Barchart · 05/19 05:13
Natural Alternatives International Delays Quarterly Filing
TipRanks · 05/18 23:28
Natural Alternatives delays Q3 10-Q filing amid new credit facility talks
PUBT · 05/18 21:03
Weekly Report: what happened at NAII last week (0511-0515)?
Weekly Report · 05/18 10:09
More
Webull provides a variety of real-time NAII stock news. You can receive the latest news about Naturl Alt Intl through multiple platforms. This information may help you make smarter investment decisions.
About NAII
Natural Alternatives International, Inc. is a formulator, manufacturer and marketer of nutritional supplements. Its primary business activity is to provide private-label contract manufacturing services to companies that market and distribute vitamins, minerals, herbs, and other nutritional supplements, as well as other health care products, to consumers both within and outside the United States. Its private-label contract manufacturing customers include companies that market nutritional supplements through direct sales marketing channels, direct to consumer ecommerce channels, and retail stores. It manufactures products in a variety of forms, including capsules, tablets, chewable wafers, and powders to accommodate a variety of its customer's preferences. It also seeks to commercialize its patent and trademarks through the direct distribution and sale of CarnoSyn, SR CarnoSyn, TriBsyn, new contract manufacturing opportunities, and various license, royalty, and similar arrangements.